Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dialysis dementia.

J R Mach1, W P Korchik, M W Mahowald

  • 1University of Minnesota, Geriatric Research Education Clinical Center, Minneapolis.

Clinics in Geriatric Medicine
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Sleep medicine·2013
Same author

Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population.

Neurology·2012
Same author

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.

Brain : a journal of neurology·2007
Same author

Objective structured clinical examinations (OSCE) for sleep.

Sleep medicine·2005
Same author

Rem sleep without atonia--from cats to humans.

Archives italiennes de biologie·2004
Same author

Severe, childhood-onset, idiopathic, life-long insomnia responding selectively to opiate therapy: case report with 19 year follow-up.

Sleep medicine·2003

Dialysis dementia, a neurologic issue in chronic kidney failure patients, is primarily caused by aluminum toxicity. Reducing aluminum exposure significantly lowers its incidence, with early deferoxamine treatment showing effectiveness.

Area of Science:

  • Nephrology
  • Neurology
  • Toxicology

Background:

  • Dialysis dementia is a serious neurologic complication in patients undergoing chronic dialysis for renal failure.
  • Aluminum toxicity is strongly implicated as the primary cause of dialysis dementia's pathogenesis.

Purpose of the Study:

  • To summarize the understanding of dialysis dementia, focusing on its cause and management.
  • To highlight the impact of aluminum reduction strategies on disease incidence.

Main Methods:

  • Review of existing literature on dialysis dementia.
  • Analysis of the role of aluminum in pathogenesis.
  • Evaluation of treatment strategies, including deferoxamine.

Main Results:

Related Experiment Videos

  • Aluminum toxicity is the major factor in dialysis dementia.
  • Decreased dialysate aluminum levels and reduced oral aluminum intake have led to a significant reduction in disease incidence.
  • Deferoxamine is effective in early stages but carries risks with chronic use.

    • Conclusions:

    • Aluminum exposure is the key factor in dialysis dementia.
    • Preventive measures targeting aluminum reduction are highly effective.
    • Early intervention with deferoxamine is beneficial, but potential complications must be considered.